leisure time -WSS

leisure time

author：hotspot 2025-08-23 08:12:37 - browse：5

CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with liver cancer in early clinical data presented Monday at the American Society of Clinical Oncology annual meeting. The study, though preliminary and small with only 24 patients, represents a triad of firsts for one of the trial’s sponsors.

“It’s the first CAR therapy working in liver cancer. First validation of targeting GPC3 as a target. It’s the first validation of our armoring strategy. And it’s the first of many of our visions of CAR therapy in general,” Matt Hellmann, a medical oncologist and early development oncology lead at AstraZeneca, said in an interview.

This abstract, presented by cancer researcher Qi Zhang of Zhejiang University School of Medicine, is yet another significant showing by AstraZeneca at this ASCO. The company had two plenary presentations on its blockbuster lung cancer drug Tagrisso and immunotherapy drug Imfinzi — as well as new results on Enhertu, which AstraZeneca developed with Daiichi Sankyo.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Vivek Ramaswamy made waves in the debate, much as in biotech

WSS

Delta passengers in Vegas fall sick while waiting on flight in triple

How the drug

Intellia plays down concerns on accidental germline transmission

FDA greenlights medical device to combat bladder issues

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Guidelines to prevent youth baseball injuries need more muscle

Delta passengers in Vegas fall sick while waiting on flight in triple

Cancer drug shortages should be causing more outrage

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CDC says it’s too soon to assess risk posed by Covid subvariant

Medicare details structure of new drug price negotiation program

Hospital at home shows how to bring innovation to health care

Hepatitis C has a cure — but many Americans still lack access to it

Stanford president’s abrupt resignation sparks debate

knowledge

National associations that represent hospice owe an apology

After a decade, new Gardasil ad campaign gets it (mostly) right

US jobless claims fall again as labor market continues to flash strength

Hospital at home shows how to bring innovation to health care

In rare move, senator releases unverified FBI source report alleging Biden bribe

As obesity drug market grows, telehealth companies court payers

focus

Wikipedia

focus

Wikipedia